Huntley rates the stock as accumulate again this week @36 cents.
Overview
The US office with the UK and Australian offices
provides access into every regional time zone. CCE now has a base to 33 countries. The strategy
for the US market is slightly different with a number of strategic agents in each state. This strategy
provides greater product control and enables the direct selling of product to large accounts. Ony two employees make up the US office but may change once FDA approved.
CCE invested capital is not pushed into development and research cost but into commercialisation. It is slowly building up cash flows so risk is a lot less.
This will translate to rapidly growing cash flow and hence maintain coverage with an accumulate/spec buy rating.
This is only an overview as Huntleys report was considerably more detailed. Well worth the purchase.
- Forums
- ASX - By Stock
- CCE
- featured in huntley again
featured in huntley again
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CCE (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.64M |
Open | High | Low | Value | Volume |
4.0¢ | 4.4¢ | 4.0¢ | $17.39K | 431.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 150191 | 4.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.5¢ | 25513 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 150191 | 0.041 |
2 | 19468 | 0.040 |
5 | 268735 | 0.039 |
5 | 223000 | 0.038 |
3 | 140883 | 0.036 |
Price($) | Vol. | No. |
---|---|---|
0.045 | 25513 | 2 |
0.046 | 199782 | 1 |
0.047 | 71297 | 2 |
0.048 | 22000 | 1 |
0.049 | 270428 | 2 |
Last trade - 15.20pm 05/08/2024 (20 minute delay) ? |
Featured News
CCE (ASX) Chart |